Press Releases

Hovione acquires ExtremoChem and its portfolio of proprietary sugars to support customers with stabilization and delivery of biopharmaceuticals

CD Formulation Offers a 10% Discount on All Products and Services as Thanksgiving Greetings for 2023

Revolutionizing Vaccine Development: Creative Biolabs Leads the Way

With the spotlight on mRNA vaccines post the prestigious Nobel Prize in Physiology or Medicine 2023, Creative Biolabs stands poised to revolutionize this groundbreaking technology.

NorthEdge invests in sterile injectable CMO to accelerate international growth

Unleashing the Power of Graphene-Silicon-Carbon Composites: Alfa Chemistry at the Forefront

CluePoints wins SCRIP Awards for Best Contract Research Organization (CRO): Specialist Providers

CluePoints wins SCRIP Awards for Best Contract Research Organization (CRO): Specialist Providers Company wins prestigious accolade for commitment to innovation and education.

Telomere Length Aging Clocks Platform to Complete Comprehensive Telomere Length Measurement and Analysis

Symbio & Dow Group Merges with Proinnovera to Form Leading Dermatology CRO, Symbio Proinnovera

A major new merger has taken place in the field of clinical research resulting in the formation of Symbio Proinnoveraone, one of the world’s largest dermatology CROs.

CD Formulation Introduces Powder Flowability Testing to Maximize Tablet Performance

Alfa Chemistry Helps Partners Achieve mRNA Vaccine Excellence: Development, Production, Optimization, Quality Control

Huateng Pharma Elevates Diabetes Drug Development with High-Purity Anti-Diabetes Intermediates

Huateng Pharma introduces advanced anti-diabetes intermediates, such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide, representing a major step in diabetes treatment. These high-purity compounds have the potential to revolutionize drug development. Huateng Pharma also offers CDMO services to promote collaboration in the pharmaceutical industry.

Biopharma PEG Elevates ADC Development with Monodispersed PEGs in Versatile Scales

Biopharma PEG introduces monodispersed PEGs, including mPEG36-NH2,NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA , for ADC development at diverse scales. R&D Director highlights their role in modulating ADC properties.

uMotif and Cogstate Power CNS Research, Combining Patient-Centric eCOA/ePRO Data Capture Platform with Market-Leading Cognitive Solutions

Companies building on existing studies in areas including psychedelics to better support CNS research with innovations to quantifiably increase data quality, improve study timelines, and enhance the clinical trial site and patient experience

Inizio Medical Calls for Urgent Action to Adopt AI in All Aspects of Healthcare Communication

One of the world’s leading communication companies Inizio Medical has issued an urgent call to action for businesses to adopt AI in all aspects of healthcare communication or risk being left behind by their competitors.

Groundbreaking treatment for Alcohol Use Disorder shown to halve alcohol consumption amongst heavy drinkers in three months at phase II: a new hope for patients

• The trial showed that KT-110 has superior efficacy in reducing alcohol consumption • KT-110 will be deliverable in a once-daily tablet (proprietary formulation) • KT-110’s mode of action is novel to Alcohol Use Disorder (AUD) and works by simultaneously modulating the noradrenergic and serotonergic brain receptors that counteract the neurobiological processes involved in addiction • Alcohol dependence, or AUD, is a serious public health issue and the medical need for the treatment of alcoholism is considerable and unmet • Kinnov Therapeutics expects to have clear guidance from the FDA in early 2024 on the phase III trial

Simbec-Orion and biotx.ai launch strategic partnership to de-risk early-stage drug development with AI supported clinical trial design

Simbec-Orion, a full-service mid-size CRO, and biotx.ai, a developer of AI-enabled causal modelling for drug development, have announced their strategic partnership to bring AI-powered insights and predictive models to support data-driven clinical trial design.

Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma, a leading China-based bioanalytical CRO

CD BioSciences Releases Biophysical Analysis Services to Speed Up Drug Discovery and Biomedical Research

Amerigo Scientific Rolls Out Real-Time PCR Kits to Facilitate HAV Research

Creative Diagnostics Launches Carbamazepine Test Reagents

Creative Diagnostics has announced the release of its new line of Carbamazepine Test Reagents.